Prostate cancer breakthrough as new drug combo gives high-risk patients a powerful new chance

Read post on independent.co.uk

Data from a late-stage trial, presented on Sunday, indicate that the treatment, administered six months before and after surgery, substantially increased the chances of eliminating cancer and reduced the risk of disease progression or death